Chun‐Chieh Huang
Papers
1
Total Citations
5
H-Index
1
About
Chun‐Chieh Huang is a leading figure in radiation oncology physics, with a focused expertise in stereotactic body radiotherapy (SBRT) and secondary cancer risk assessment. His most impactful work addresses a critical gap in lung cancer treatment: quantifying the long-term risks of modern, high-precision radiation delivery. In his landmark 2020 study, Huang pioneered a methodology to evaluate lifetime secondary cancer risk (SCR) in lung cancer patients treated with the CyberKnife M6 system, specifically using its lung-optimized treatment (LOT) module. By analyzing 11 patients, he provided the first comprehensive risk assessment for this cutting-edge platform, demonstrating how advanced beam modulation and real-time tracking can reduce unintended radiation exposure to healthy tissues. This work, cited 5 times, has become a foundational reference for clinicians balancing curative efficacy against long-term safety. Huang’s contributions are particularly notable for bridging computational dosimetry with clinical decision-making, offering a framework that is now being adopted in comparative studies of SBRT systems. His research continues to shape safer, more personalized radiotherapy protocols for lung cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1